Article
CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder.
Nature communications - 16 Nov 2022
de Thonel Aurélie, Ahlskog Johanna K, Daupin Kevin, Dubreuil Véronique, Berthelet Jérémy, Chaput Carole, Pires Geoffrey, Leonetti Camille, Abane Ryma, Barris Lluís Cordón, Leray Isabelle, Aalto Anna L, Naceri Sarah, Cordonnier Marine, Benasolo Carène, Sanial Matthieu, Duchateau Agathe, Vihervaara Anniina, Puustinen Mikael C, Miozzo Federico, Fergelot Patricia, Lebigot Élise, Verloes Alain, Gressens Pierre, Lacombe Didier, Gobbo Jessica, Garrido Carmen, Westerheide Sandy D, David Laurent, Petitjean Michel, Taboureau Olivier, Rodrigues-Lima Fernando, Passemard Sandrine, Sabéran-Djoneidi Délara, Nguyen Laurent, Lancaster Madeline, Sistonen Lea, Mezger Valérie
Abstract excerpt
Patients carrying autosomal dominant mutations in the histone/lysine acetyl transferases CBP or EP300 develop a neurodevelopmental disorder: Rubinstein-Taybi syndrome (RSTS). The biological pathways underlying these neurodevelopmental defects remain elusive. Here, we unravel the contribution of a stress-responsive pathway to RSTS. We characterize the structural and functional interaction between CBP/EP300 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
